Purposes: The aim of this study was to evaluate a dual marker-based and soft-tissue based image guidance for inter-fractional corrections in stereotactic body radiotherapy (SBRT) of prostate cancer.
| INTRODUCTION
Stereotactic body radiation therapy (SBRT) is a promising treatment regimen for localized prostate cancer because of the low a/b ratio of the prostate adenocarcinoma. 1 Several recent SBRT studies showed local control rates and toxicity profiles were comparable to the conventional dose regimen of 2 Gy per fraction (2 Gy/Fx). 2, 3 It has been reported that with a prescription dose of 7.25 Gy/Fx or higher in SBRT treatment planning, margins are usually 5 mm or smaller to spare the surrounding organs at risk such as rectum, urethra, and bladder. 1 The high-dose conformity of SBRT plans imposes a stringent requirement to the management of inter-and intra-fractional variations.
Intra-fractional motion can be managed with use of an endorectal balloon. [4] [5] [6] [7] [8] However, it may introduce a large prostate inter-fraction motion, rotation, and deformation. Jones et al. reported that 69% of fractions required insertion adjustments of the endorectal balloon to reduce prostate rotation and deformation. 6 They recommended to acquire two Cone-Beam Computed Tomography (CBCTs) for each patient: one after insertion and the other after adjustment.
With daily Image-guided Radiation Therapy (IGRT) to correct translational setup error and inter-fractional motion of the prostate, uncorrected prostate rotation became a predominant impact on the dose delivered to the prostate. With 2-, 3-, and 5-mm Planning Target Volume (PTV) margins, Amro et al. showed that only 39%, 65%, and 84% of 26 patients had adequate dose coverage to the prostate without rotation correction, respectively.
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With a tight planning margin, we implemented a two-step (dual)
IGRT protocol for patients receiving prostate SBRT treatment with endorectal balloon. The dual IGRT protocol involved with a markerbased kV x ray guidance and six dimensional (6D) corrections using a robotic couch, and a soft-tissue based kV-CBCT with 3D translational corrections. Using a dosimetric analysis, the aim of this study was to evaluate whether the dual marker-based and soft-tissue based IGRT protocol is sufficient to achieve adequate Clinical Target Volume (CTV) coverage.
| MATERIALS AND METHODS
Eighteen patients treated with five-fraction SBRT for prostate cancer were included in this study. Patients were implanted with three gold fiducial markers at apex, left and right base of their prostate glands.
A total of 84 daily dose fractions were included in the dosimetric analysis (six fractions were not included due to incomplete imaging of the anatomical volume). In 22 of 84 fractions, additional translational corrections guided by kV-CBCT were applied after the kV x ray guided 6D shifts. These 22 fractions were separately analyzed to evaluate dosimetric differences between with and without the additional kV-CBCT shifts after the 6D kV x ray guided shifts.
To minimize the position variations of the internal organs, the patients were instructed to maintain a full bladder and empty rectum before the simulation and treatments. Immediately before the acqui- All patients were planned according to our in-house protocol approved by our local institutional review board (IRB). Briefly, the prostate (CTV) and seminal vesicle (SV) were delineated as the treatment target, and rectum, urethra and bladder were delineated as organs at risks (OAR) according to our protocol. We defined high-dose avoidance zone (HDAZ) with 3 mm expansion of those OAR ( Fig. 1 ).
PTVs included low-dose PTV (LD-PTV) and high-dose PTV (HD-PTV).
The LD-PTV was a 3 mm uniform expansion of the prostate CTV On each daily verification kV-CBCT, the prostate (CTV), rectal balloon, and bladder were retrospectively delineated by the attending physicians. To remove the effect from inaccurate electron density information in kV-CBCT, an external contour was created for both planning CTs and daily kV-CBCTs in which a uniform electron density of 1 g/cm 3 was assigned. To understand dosimetric differences
between the heterogeneity and homogeneity dose calculations on a selected patient (Fig. 2) , we compared dose volume histograms (DVH) (a) override all tissue with a uniform electron density of 1 g/cm 3 (override all); (b) override the rectal balloon with electron density of 0 g/cm 3 while other tissue with electron density of 1 g/cm 3 (override balloon); (c) with heterogeneity dose calculation. The differences were less than 2%. To provide a reference for daily dose evaluation, the planning dose was then recalculated with the uniform electron density. On daily kV-CBCT, dose was calculated applying the original treatment plan with the treatment iso-center. For the 22 fractions that had additional kV-CBCT-guided shifts, to compare dosimetric outcomes with and without additional kV-CBCT-guided shift, the dose was also calculated with the beam iso-centers positioned prior to the kV-CBCT shifts.
For the evaluation of daily target coverage, the prostate (CTV) V 36.25 Gy was used since the planning goal on the HD-PTV coverage was not a priority. The D 0.03 cc of the rectal wall was used to evaluate the daily dose toxicity. The rectal wall was created by placing a 2-mm thick ring just outside the rectal balloon surface on both daily kV-CBCTs and planning CTs. The bladder D 0.03 cc was used to evaluate daily bladder dose.
Descriptive statistics were used for data analysis. The results were expressed as mean AE standard deviation. Wilcoxon signed rank test was used to compare the daily dosimetric endpoints between using the kV x ray guided shifts alone and with the additional kV-CBCT guided shifts. Statistical significance was assigned at P < 0.05. Differences between the soft-tissue alignment using kV-CBCT and the fiducial marker alignment using 2D kV x ray have been reported in several studies. [10] [11] [12] Using independent soft-tissue align- with our results, although we used two-step alignments instead of two independent alignments. Several studies 7, 8 indicated that utilizing an endorectal balloon can effectively immobilize prostate and restrict rectal filling. The use of endorectal balloon, however, may introduce a large inter-fraction prostate motion and deformation. 4 Neither translational nor rotational correction can resolve issues of organ deformation and organ shape changes. Therefore, online adaptive replanning strategies [13] [14] [15] [16] may provide an optimal solution while maintaining tight planning margins. Without online adaptive planning, alternative strategy is to minimize inter-fractional prostate deformation and rotation. Instead of inserting the rectal balloon, one can use the transperineal ultrasound to monitor intra-prostate motion. Instead of using implanted markers as the surrogate of the prostate, one can directly align to the prostate soft tissue.
| RESULTS
One limitation of this study is no consideration of the intra-fractional variation, although other studies have shown the effectiveness of prostate immobilization with the use of rectal balloon. 4, 7, 8 A recent prostate SBRT study also showed that the compensation of intra-fractional motion on a beam-by-beam basis has very little impact on the final dose parameters. 16 Therefore, we believe that the prostate motion between the two IGRT acquisition time delta is negligible.
It has been reported that alignment to markers often results in a larger rotation than with soft-tissue alignment. 17 CBCT is adequate for soft-tissue alignment to eliminate the implant markers has been debated. 19 Despite non-ideal dosimetric coverage, our clinical outcome study for this group of patients reported a favorable rate of biochemical control and acceptably low rate of acute and long-term GU and GI toxicities. 
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